Axogen Inc vs Freeport-McMoRan Inc — how do they compare? Axogen Inc trades at $38.69 (market cap $2.06B), while Freeport-McMoRan Inc trades at $61.02 (market cap $89.06B). The key difference: Freeport-McMoRan Inc is far larger — about 43.2× Axogen Inc's market cap, and Freeport-McMoRan Inc pays a 0.97% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | FCX | |
|---|---|---|
Market Cap | $2.06B | $89.06B |
Sector | Technology | Basic Materials |
52-Week High | $46.19 | $71.73 |
52-Week Low | $11.28 | $35.34 |
Enterprise Value | $1.98B | $95.72B |
Dividend Yield | — | 0.97% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
FCX trades at $59.98, down 2.51% today, with a bearish technical signal but strong fundamentals. Recent earnings beats and a 10.34% net income margin highlight operational strength. The stock faces near-term resistance at $61, with support at $59. Analysts maintain a $72.94 consensus target, reflecting 22% upside potential. Copper demand growth and expansion projects support long-term prospects.
Outlook remains positive driven by copper's structural supply-demand imbalance and FCX's cost leadership. Risks include commodity price volatility and execution challenges in new projects. Institutional sentiment is bullish with 59% buy ratings, though technical indicators suggest near-term consolidation. The dividend yield of 0.25% provides modest income support.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →